In 2008 the FDA released a warning regarding problems with pelvic mesh implants like the Bard Avaulta, noting that complications with the mesh implant have been linked to the design of the vaginal mesh.  The mesh is surgically implanted in order to prevent pelvic organ prolapse, or POP, a condition in which the pelvic organs, such as the bladder, uterus, rectum or vagina, slip out of place.  POP can occur in women after childbirth or surgery.  In many cases, however, the implantation of the mesh has caused some of the following complications: pelvic pain, extrusion of the mesh device, infection, removal of the mesh device, scarring, hardening of the mesh device, and difficulties during sex.  A number of women have had to have a second surgery to remove the sling, sometimes leaving permanent disfiguration.

Defective medical device attorneys across the country have begun filing complaints against Bard, alleging that the negligent design of the vaginal sling has put women at greater risk for infection, severe pain and suffering, and increased risk for additional surgery.  Women negatively affected by the design of the pelvic mesh implants are seeking compensation from the manufacturer for the complications they have endured.